サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1381655

アレルギー免疫療法の世界市場規模調査＆予測、治療タイプ別、アレルギータイプ別、流通チャネル別、地域別分析、2023～2030年

Global Allergy Immunotherapy Market Size study & Forecast, by Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy ) by Allergy Type, by Distribution Channel and Regional Analysis, 2023-2030

出版日
ページ情報
英文
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
アレルギー免疫療法の世界市場規模調査＆予測、治療タイプ別、アレルギータイプ別、流通チャネル別、地域別分析、2023～2030年
出版日: 2023年10月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アレルギー免疫療法の世界市場は、2022年に約20億7,000万米ドルと評価され、予測期間2023～2030年には9.0%以上の成長率で成長すると予測されています。

アレルギー免疫療法は、アレルギーの医学的治療法です。花粉、ダニ、ペットのフケ、特定の昆虫毒など、特定のアレルゲンに対する免疫系の減感作を目的とした長期的な治療法です。アレルギー免疫療法の目的は、アレルゲンに対する免疫反応を変化させ、アレルギー症状を軽減させることです。アレルギー性鼻炎（花粉症）、アレルギー性喘息、昆虫毒アレルギーの治療に有効です。アレルギー予防注射は、治療終了後も長期にわたって症状を緩和することができます。アレルギー免疫療法市場は、様々な種類のアレルギーの負担増加や個別化医療に対する需要の高まりなどの要因により拡大しています。

American College of Allergy, Asthma &Immunologyの情報によると、毎年5,000万人以上のアメリカ人がアレルギーに悩まされています。また、例えばSingleCare社が2022年1月に発表した学術論文によると、毎年5000万人以上のアメリカ人が何らかのアレルギーを経験していると推定されています。同様に、2050年におけるインド全土の高齢者の喘息患者数は約2,540万人になると予想されています。さらに、アレルギーは米国で6番目に多い慢性疾患であることも指摘されています。さらに、シングルケアが2021年に実施した調査では、アレルギーを持つ回答者の82.0％が、米国ではアレルギーが生活の質に影響を与えていると感じていることがわかっています。このように、地域全体でアレルギーの罹患率が上昇していることが市場成長の原動力となっています。また、舌下投与製剤の技術的進歩や強力な製品パイプラインの存在が、市場成長に有利な機会を生み出しています。しかし、アレルギー免疫療法の調査費用が高いことや、アレルギー免疫療法の使用に伴う欠点、代替治療法の利用可能性が、2023～2030年の予測期間を通じて市場成長を阻害しています。

アレルギー免疫療法の世界市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカなどです。北米は、主要市場参入企業の優位性、アレルギー疾患の増加、同地域における製品発売活動の増加により、2022年に最大の市場シェアを獲得し、市場を独占しました。一方、アジア太平洋は、疾患罹患率の上昇、同地域における主要市場参入企業の事業拡大、同地域における啓発プログラムの増加などの要因により、最も速い成長が予測されています。

本調査の目的は、近年における様々なセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することです。本レポートは、調査対象国における産業の質的・量的側面の両方を盛り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題などの重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のアレルギー免疫療法市場の定義と範囲

  • 調査目的
  • 市場の定義と範囲
    • 産業の進化
    • 調査範囲
  • 調査対象年
  • 通貨換算レート

第3章 アレルギー免疫療法の世界市場力学

  • アレルギー免疫療法市場の影響分析（2020～2030年）
    • 市場促進要因
      • 各種アレルギーの負担増
      • 個別化医療に対する需要の高まり
    • 市場の課題
      • アレルギー免疫療法の高コスト
      • アレルギー免疫療法
    • 市場機会
      • 舌下投与製剤の技術的進歩
      • 強力な製品パイプラインの存在

第4章 アレルギー免疫療法の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォース影響分析
  • PEST分析
    • 政治的
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主な投資機会
  • 主要成功戦略
  • COVID-19影響分析
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 アレルギー免疫療法の世界市場：治療タイプ別

  • 市場スナップショット
  • アレルギー免疫療法の世界市場：治療タイプ別、実績・ポテンシャル分析
  • アレルギー免疫療法の世界市場：治療タイプ別、推定・予測、2020～2030年
  • アレルギー免疫療法市場、サブセグメント分析
    • 皮下免疫療法（SCIT）
    • 舌下免疫療法（SLIT）

第6章 アレルギー免疫療法の世界市場：アレルギータイプ別

  • 市場スナップショット
  • アレルギー免疫療法の世界市場：アレルギータイプ別、実績・ポテンシャル分析
  • アレルギー免疫療法の世界市場：アレルギータイプ別、推定・予測、2020～2030年
  • アレルギー免疫療法の世界市場、サブセグメント別分析
    • アレルギー性鼻炎
    • アレルギー性喘息
    • その他

第7章 アレルギー免疫療法の世界市場：流通チャネル別

  • 市場スナップショット
  • アレルギー免疫療法の世界市場：流通チャネル別、実績・ポテンシャル分析
  • アレルギー免疫療法の世界市場：流通チャネル別、推定・予測、2020～2030年
  • アレルギー免疫療法市場、サブセグメント分析
    • 病院薬局
    • 小売薬局
    • オンライン薬局

第8章 アレルギー免疫療法の世界市場：地域別分析

  • 主要国
  • 主な新興国
  • アレルギー免疫療法市場、地域別市場スナップショット
  • 北米
    • 米国
      • 治療タイプ、推定・予測、2020～2030年
      • アレルギータイプ、推定・予測、2020～2030年
      • 流通チャネル別、推定・予測、2020～2030年
    • カナダ
  • 欧州のアレルギー免疫療法市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他の欧州
  • アジア太平洋のアレルギー免疫療法市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋
  • ラテンアメリカのアレルギー免疫療法市場スナップショット
    • ブラジル
    • メキシコ
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • その他の中東およびアフリカ

第9章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Torii Pharmaceutical Co., Ltd.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
    • ALK-Abello A/S
    • Allergy Therapeutics
    • Biomay AG
    • Allovate, LLC
    • HAL Allergy Group
    • Jubliant Pharma（Hollister Allergy）
    • Leti Pharma
    • Merck KGaA（Allergopharma）
    • Stallergenes Greer

第10章 調査プロセス

  • 調査プロセス
    • データ鉱業
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
  • 調査前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Allergy Immunotherapy Market, report scope
  • TABLE 2. Global Allergy Immunotherapy Market estimates & forecasts by Region 2020-2030 (USD Billion)
  • TABLE 3. Global Allergy Immunotherapy Market estimates & forecasts by Treatment Type 2020-2030 (USD Billion)
  • TABLE 4. Global Allergy Immunotherapy Market estimates & forecasts by Allergy Type 2020-2030 (USD Billion)
  • TABLE 5. Global Allergy Immunotherapy Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
  • TABLE 6. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 7. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 8. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 9. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 10. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 11. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 12. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 13. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 14. Global Allergy Immunotherapy Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 15. Global Allergy Immunotherapy Market by region, estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 16. U.S. Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 17. U.S. Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 18. U.S. Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 19. Canada Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 20. Canada Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 21. Canada Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 22. UK Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 23. UK Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 24. UK Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 25. Germany Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 26. Germany Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 27. Germany Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 28. France Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 29. France Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 30. France Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 31. Italy Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 32. Italy Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 33. Italy Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 34. Spain Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 35. Spain Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 36. Spain Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 37. RoE Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 38. RoE Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 39. RoE Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 40. China Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 41. China Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 42. China Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 43. India Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 44. India Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 45. India Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 46. Japan Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 47. Japan Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 48. Japan Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 49. South Korea Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 50. South Korea Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 51. South Korea Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 52. Australia Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 53. Australia Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 54. Australia Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 55. RoAPAC Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 56. RoAPAC Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 57. RoAPAC Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 58. Brazil Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 59. Brazil Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 60. Brazil Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 61. Mexico Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 62. Mexico Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 63. Mexico Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 64. RoLA Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 65. RoLA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 66. RoLA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 67. Saudi Arabia Allergy Immunotherapy Market estimates & forecasts, 2020-2030 (USD Billion)
  • TABLE 68. South Africa Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 69. RoMEA Allergy Immunotherapy Market estimates & forecasts by segment 2020-2030 (USD Billion)
  • TABLE 70. List of secondary sources, used in the study of global Allergy Immunotherapy Market
  • TABLE 71. List of primary sources, used in the study of global Allergy Immunotherapy Market
  • TABLE 72. Years considered for the study
  • TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

  • FIG 1. Global Allergy Immunotherapy Market, research methodology
  • FIG 2. Global Allergy Immunotherapy Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Allergy Immunotherapy Market, key trends 2022
  • FIG 5. Global Allergy Immunotherapy Market, growth prospects 2023-2030
  • FIG 6. Global Allergy Immunotherapy Market, porters 5 force model
  • FIG 7. Global Allergy Immunotherapy Market, pest analysis
  • FIG 8. Global Allergy Immunotherapy Market, value chain analysis
  • FIG 9. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 10. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 11. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 12. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 13. Global Allergy Immunotherapy Market by segment, 2020 & 2030 (USD Billion)
  • FIG 14. Global Allergy Immunotherapy Market, regional snapshot 2020 & 2030
  • FIG 15. North America Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 16. Europe Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 17. Asia pacific Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 18. Latin America Allergy Immunotherapy Market 2020 & 2030 (USD Billion)
  • FIG 19. Middle East & Africa Allergy Immunotherapy Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Allergy Immunotherapy Market is valued at approximately USD 2.07 billion in 2022 and is anticipated to grow with a growth rate of more than 9.0% over the forecast period 2023-2030. Allergy immunotherapy is a medical treatment for allergies. It is a long-term therapy that aims to desensitize a person's immune system to specific allergens, such as pollen, dust mites, pet dander, or certain insect venoms. The goal of allergy immunotherapy is to modify the immune response to allergens, leading to a reduction in allergy symptoms. It can be effective in treating allergic rhinitis (hay fever), allergic asthma, and insect venom allergies. Allergy shots can provide long-term relief, even after the treatment is completed. The Allergy Immunotherapy market is expanding because of factors such as the increasing burden of various types of allergies and rising demand for personalized medicine.

According to Information form the American College of Allergy, Asthma & Immunology, more than 50 million Americans suffer from allergies each year. In addition, for instance, a journal paper published by SingleCare in January 2022 estimates that more than 50.0 million Americans experience an allergy of some form each year. Similarly, The number of cases of asthma in Indian senior citizens across the India in 2050 was anticipated to be about 25.4 million cases. Furthermore, it noted that allergies rank as the sixth-most prevalent chronic illness in the US. In addition, a survey conducted by SingleCare in 2021 found that 82.0% of respondents who had allergies felt their allergies had an impact on their quality of life in the US. Thus, rising incidence of allergies across the regions is driving the market growth. In addition, technological advancements in sublingual dosage formulations and presence of strong product pipeline are creating a lucrative opportunity to the market growth. However, the high cost of allergy immunotherapy research and drawbacks associated with the use of allergy immunotherapy and availability of alternative treatments stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Allergy Immunotherapy Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share owing to the dominance of key market players, rising prevelance of allergy disorders, rising number of product launch activities in the region. Whereas, Asia Pacific region is projected to have fastest growth owing to factors such as rising disease prevelance, rising expansion by key market players in the region as well as rising number of awareness programs in the region.

Major market player included in this report are:

  • Torii Pharmaceutical Co., Ltd.
  • ALK-Abello A/S
  • Allergy Therapeutics
  • Biomay AG
  • Allovate, LLC
  • HAL Allergy Group
  • Jubliant Pharma (Hollister Allergy)
  • Leti Pharma
  • Merck KGaA (Allergopharma)
  • Stallergenes Greer

Recent Developments in the Market:

  • In January 2023, HollisterStier Allergy unveiled Ultrafiltered Dog, its most recent product innovation. Patients who are sensitive to dogs can be diagnosed and treated successfully with the product.
  • In June 2022, ALK began a phase I clinical research in North America for their brand-new sublingual tablet intended to treat peanut allergy.

Global Allergy Immunotherapy Market Report Scope:

  • Historical Data - 2020 - 2021
  • Base Year for Estimation - 2022
  • Forecast period - 2023-2030
  • Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered - Treatment Type, Allery Type, Distribution Channel, Region
  • Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

By Allergy Type:

  • Allergic rhinitis
  • Allergic asthma
  • Others

By Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
    • 1.2.1. Allergy Immunotherapy Market, by region, 2020-2030 (USD Billion)
    • 1.2.2. Allergy Immunotherapy Market, by Treatment Type, 2020-2030 (USD Billion)
    • 1.2.3. Allergy Immunotherapy Market, by Allergy Type, 2020-2030 (USD Billion)
    • 1.2.4. Allergy Immunotherapy Market, by Distribution Channel, 2020-2030 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Allergy Immunotherapy Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Allergy Immunotherapy Market Dynamics

  • 3.1. Allergy Immunotherapy Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing burden of various types of allergies
      • 3.1.1.2. Rising demand for personalized medicine
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Allergy Immunotherapy
      • 3.1.2.2. Allergy Immunotherapy
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Technological advancements in sublingual dosage formulations
      • 3.1.3.2. Presence of strong product pipeline

Chapter 4. Global Allergy Immunotherapy Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Allergy Immunotherapy Market, by Treatment Type

  • 5.1. Market Snapshot
  • 5.2. Global Allergy Immunotherapy Market by Treatment Type, Performance - Potential Analysis
  • 5.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Treatment Type 2020-2030 (USD Billion)
  • 5.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 5.4.1. Subcutaneous Immunotherapy (SCIT)
    • 5.4.2. Sublingual Immunotherapy (SLIT)

Chapter 6. Global Allergy Immunotherapy Market, by Allergy Type

  • 6.1. Market Snapshot
  • 6.2. Global Allergy Immunotherapy Market by Allergy Type, Performance - Potential Analysis
  • 6.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Allergy Type 2020-2030 (USD Billion)
  • 6.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 6.4.1. Allergic rhinitis
    • 6.4.2. Allergic asthma
    • 6.4.3. Others

Chapter 7. Global Allergy Immunotherapy Market, by Distribution Channel

  • 7.1. Market Snapshot
  • 7.2. Global Allergy Immunotherapy Market by Distribution Channel, Performance - Potential Analysis
  • 7.3. Global Allergy Immunotherapy Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
  • 7.4. Allergy Immunotherapy Market, Sub Segment Analysis
    • 7.4.1. Hospital Pharmacy
    • 7.4.2. Retail Pharmacy
    • 7.4.3. Online Pharmacy

Chapter 8. Global Allergy Immunotherapy Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Allergy Immunotherapy Market, Regional Market Snapshot
  • 8.4. North America Allergy Immunotherapy Market
    • 8.4.1. U.S. Allergy Immunotherapy Market
      • 8.4.1.1. Treatment Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Allergy Type breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Allergy Immunotherapy Market
  • 8.5. Europe Allergy Immunotherapy Market Snapshot
    • 8.5.1. U.K. Allergy Immunotherapy Market
    • 8.5.2. Germany Allergy Immunotherapy Market
    • 8.5.3. France Allergy Immunotherapy Market
    • 8.5.4. Spain Allergy Immunotherapy Market
    • 8.5.5. Italy Allergy Immunotherapy Market
    • 8.5.6. Rest of Europe Allergy Immunotherapy Market
  • 8.6. Asia-Pacific Allergy Immunotherapy Market Snapshot
    • 8.6.1. China Allergy Immunotherapy Market
    • 8.6.2. India Allergy Immunotherapy Market
    • 8.6.3. Japan Allergy Immunotherapy Market
    • 8.6.4. Australia Allergy Immunotherapy Market
    • 8.6.5. South Korea Allergy Immunotherapy Market
    • 8.6.6. Rest of Asia Pacific Allergy Immunotherapy Market
  • 8.7. Latin America Allergy Immunotherapy Market Snapshot
    • 8.7.1. Brazil Allergy Immunotherapy Market
    • 8.7.2. Mexico Allergy Immunotherapy Market
  • 8.8. Middle East & Africa Allergy Immunotherapy Market
    • 8.8.1. Saudi Arabia Allergy Immunotherapy Market
    • 8.8.2. South Africa Allergy Immunotherapy Market
    • 8.8.3. Rest of Middle East & Africa Allergy Immunotherapy Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Torii Pharmaceutical Co., Ltd.
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. ALK-Abello A/S
    • 9.3.3. Allergy Therapeutics
    • 9.3.4. Biomay AG
    • 9.3.5. Allovate, LLC
    • 9.3.6. HAL Allergy Group
    • 9.3.7. Jubliant Pharma (Hollister Allergy)
    • 9.3.8. Leti Pharma
    • 9.3.9. Merck KGaA (Allergopharma)
    • 9.3.10. Stallergenes Greer

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption